Literature DB >> 3493777

Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.

M Kitada, T Kamataki, K Itahashi, T Rikihisa, Y Kanakubo.   

Abstract

The purpose of this study was to clarify the pharmacological and physiological significance of P-450 HFLa. Thus, correlations between cytochrome P-450 (P-450 HFLa) level and different monooxygenase activities were investigated in liver homogenates from human fetuses. Poor correlation was seen between P-450 HFLa level and the activity of benzphetamine N-demethylation or aniline hydroxylation. In contrast, the content of P-450 HFLa was highly correlated with the activity of benzo(a)pyrene hydroxylation, 7-ethoxycoumarin O-deethylation or testosterone 6 beta-hydroxylation. In microsomes from human adult livers, a moderate relationship was also observed between testosterone 6 beta-hydroxylation and P-450 HFLa level. Furthermore, antibodies to P-450 HFLa inhibited testosterone 6 beta-hydroxylase activity in fetal and adult livers to similar extents. We conclude that P-450 HFLa is a form of cytochrome P-450 which catalyzes testosterone 6 beta-hydroxylation and limited drug oxidations in human fetal and adult livers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493777     DOI: 10.1016/0006-2952(87)90350-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Three cases of severe hepatic impairment caused by erlotinib.

Authors:  Yi-Sheng Huang; She-Juan An; Zhi-Hong Chen; Yi-Long Wu
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

Review 2.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

3.  Differences in adult and foetal human cytochrome P-450 forms recognized by monoclonal antibodies with specificity for the P450III family.

Authors:  T S Barnes; M D Burke; W T Melvin
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

4.  The lithocholic acid 6 beta-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6 beta-hydroxylation.

Authors:  T K Chang; J Teixeira; G Gil; D J Waxman
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

Review 5.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.

Authors:  C Cazeneuve; G Pons; E Rey; J M Treluyer; T Cresteil; G Thiroux; P D'Athis; G Olive
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.

Authors:  J D Schuetz; S Kauma; P S Guzelian
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 8.  The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.

Authors:  Brooke M VandenBrink; Nina Isoherranen
Journal:  Curr Opin Drug Discov Devel       Date:  2010-01

9.  Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.

Authors:  Sylvie E Kandel; Lyrialle W Han; Qingcheng Mao; Jed N Lampe
Journal:  Drug Metab Dispos       Date:  2017-10-06       Impact factor: 3.922

10.  Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head.

Authors:  Wei He; Keda Li
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.